Considering that MHC plays a key role in antigen presentation, it is reasonable to suggest that Birinapant may improve the antigen presentation of tumor cells, rendering them more easily recognized by T lymphocytes; nevertheless, the specific mechanism remains elusive. This evidence concerns the gene HLA-C and neoplasm.